tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market

Glenmark Pharmaceuticals Limited (GLENMARK) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

GLENMARK Financial Forecast

GLENMARK Earnings Forecast

Next quarter’s earnings estimate for GLENMARK is ₹12.10 with a range of ₹12.10 to ₹12.10. The previous quarter’s EPS was ₹12.30. GLENMARK beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.61% of the time in the same period. In the last calendar year GLENMARK has Outperformed its overall industry.
Next quarter’s earnings estimate for GLENMARK is ₹12.10 with a range of ₹12.10 to ₹12.10. The previous quarter’s EPS was ₹12.30. GLENMARK beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.61% of the time in the same period. In the last calendar year GLENMARK has Outperformed its overall industry.

GLENMARK Sales Forecast

Next quarter’s sales forecast for GLENMARK is ₹33.74B with a range of ₹33.02B to ₹35.22B. The previous quarter’s sales results were ₹33.88B. GLENMARK beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.00% of the time in the same period. In the last calendar year GLENMARK has Preformed in-line its overall industry.
Next quarter’s sales forecast for GLENMARK is ₹33.74B with a range of ₹33.02B to ₹35.22B. The previous quarter’s sales results were ₹33.88B. GLENMARK beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.00% of the time in the same period. In the last calendar year GLENMARK has Preformed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Glenmark Pharmaceuticals Limited

Which Analyst Should I Follow If I Want to Buy IN:GLENMARK and Sell After:
1 Month
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-11.70%
upgraded a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -11.70% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-11.70%
upgraded a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -11.70% per trade.
1 Year
Success Rate
0/1 ratings generated profit
0%
Average Return
-11.70%
upgraded a buy rating 29 days ago
Copying Damayanti Kerai's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -11.70% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-11.70%
upgraded a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -11.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GLENMARK Analyst Recommendation Trends

Rating
Mar 25
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
total
2
In the current month, GLENMARK has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. GLENMARK average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

GLENMARK Stock Forecast FAQ

What is IN:GLENMARK’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:GLENMARK’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:GLENMARK, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Glenmark Pharmaceuticals Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Glenmark Pharmaceuticals Limited’s share price target?
      Currently, no data Available
      What do analysts say about Glenmark Pharmaceuticals Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Glenmark Pharmaceuticals Limited?
      To buy shares of IN:GLENMARK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis